MyD88 and TLR4 expression in epithelial ovarian cancer (2018)
Source: Mayo Clinic Proceedings. Unidade: FMRP
Subjects: BIOMARCADORES, CARCINOMA, OVÁRIO, IMUNOHISTOQUÍMICA, NEOPLASIAS OVARIANAS, ANÁLISE DE SOBREVIVÊNCIA
ABNT
TIEZZI, Daniel Guimarães e REIS, Francisco José Cândido dos. MyD88 and TLR4 expression in epithelial ovarian cancer. Mayo Clinic Proceedings, v. 93, n. 3, p. 307-320, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.mayocp.2017.10.023. Acesso em: 14 out. 2024.APA
Tiezzi, D. G., & Reis, F. J. C. dos. (2018). MyD88 and TLR4 expression in epithelial ovarian cancer. Mayo Clinic Proceedings, 93( 3), 307-320. doi:10.1016/j.mayocp.2017.10.023NLM
Tiezzi DG, Reis FJC dos. MyD88 and TLR4 expression in epithelial ovarian cancer [Internet]. Mayo Clinic Proceedings. 2018 ; 93( 3): 307-320.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.mayocp.2017.10.023Vancouver
Tiezzi DG, Reis FJC dos. MyD88 and TLR4 expression in epithelial ovarian cancer [Internet]. Mayo Clinic Proceedings. 2018 ; 93( 3): 307-320.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.mayocp.2017.10.023